Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Total Debt (2020 - 2025)

Historic Total Debt for Alvotech (ALVO) over the last 6 years, with Q3 2025 value amounting to $1.1 billion.

  • Alvotech's Total Debt rose 935.57% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 935.57%. This contributed to the annual value of $1.1 billion for FY2024, which is 1129.24% up from last year.
  • Per Alvotech's latest filing, its Total Debt stood at $1.1 billion for Q3 2025, which was up 935.57% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Alvotech's Total Debt ranged from a high of $1.1 billion in Q3 2025 and a low of $400.9 million during Q4 2021
  • For the 5-year period, Alvotech's Total Debt averaged around $882.4 million, with its median value being $960.2 million (2023).
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 2940.45% in 2021, then surged by 9070.82% in 2022.
  • Quarter analysis of 5 years shows Alvotech's Total Debt stood at $400.9 million in 2021, then surged by 90.71% to $764.6 million in 2022, then rose by 25.58% to $960.2 million in 2023, then increased by 11.29% to $1.1 billion in 2024, then increased by 5.22% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.